Tuberculosis detection in the Asian elephant (Elephas Maximus) population in Thailand by Bontekoning, I.


Tuberculosis detection in the Asian elephant (Elephas Maximus) population of Thailand
	development of an IFNγ assay


























Research project from September 2009 – December 2009 

Kasetsart University, Bangkok, Thailand
Chiang Mai University, Chiang Mai, Thailand
Utrecht University, Utrecht, Holland












-	Part I : expression of IFNγ					11
-	Part II: iELISA and RT						13

Results									16
-	Part I : expression of IFNγ					16













As tuberculosis might be a problem in the declining Asian elephant population but too little is known about the exact prevalence of this disease, researchers in Bangkok, Chiang Mai, Utrecht and Pretoria are currently busy developing blood tests for detecting tuberculosis in elephants. During this research project, I participated in the development of an IFNγ assay by working on the expression of glycosylated IFNγ from insect cells, to be used as a positive control in the development of the IFNγ assay. I also evaluated sensitivity, specificity, positive and negative predictive value of indirect (i)ELISA tests employing ESAT6/CFP10, CFP10 & MBP83 antigens, and the commercial TB STAT-PAK rapid test.

The expression of IFNγ has encountered quite some obstacles, but we succeeded in constructing a pMT/BiP/V5-HisA vector carrying an IFNγ gene insertion (as assessed by PCR product size). This plasmid has been transferred into Schneider 2 insect cells (Drosophila melanogaster), using the Drosophila Expression System (DES®, Invitrogen). A stable expression of IFNγ by these cells has not been established yet.








The number of Asian elephants currently decreases at an alarming rate. The International Union for Conservation of Nature (IUCN) has estimated their decline at 50% in the past three generations and has put the Asian elephant on its Red List of endangered animals [24]. Captive breeding of elephants is difficult and little is known about the prevalence of diseases in elephants. That’s why Europe and Asia have set up the EU-Asia Link Project on Management of Health and Reproduction of Elephant Populations in Asia. In this three-year project, veterinary faculties of the EU and Asia collaborate to develop research capacity at Asian institutes. By academic training of staff and students in Asia, the knowledge to preserve the elephants of Asia, which are considered both a unique natural heritage and a valuable economic resource to both the agricultural and tourism sectors, can be disseminated [23].






Tuberculosis: mycobacterium tuberculosis complex
Tuberculosis is a chronic necrotizing granulomatous disease caused by the pathogenic mycobacterium tuberculosis complex (MTBC), which comprises the species Mycobacterium tuberculosis, M. bovis, M. africanum, M. microti and M. canetti [7][20]. Mycobacteria are obligate aeroob, non-spore forming, non-motile, rod shaped, acid-fast micro-organisms. Their cell walls are rich in complex lipids and waxes containing mycolic acid [16]. Mycobacteria are intracellular pathogens that reside mainly within macrophages and grow best in tissues with high oxygen tension, such as the apices of the lung or the renal cortex [10][7]. This way they are able to survive many years in a slow-replicating or non-replicating state, induced by the host immune response or fibrotic encapsulation [10]. M. tuberculosis and M. bovis are most highly pathogenic. Humans are the natural and reservoir hosts for M. tuberculosis, domestic cattle are the natural and reservoir hosts for M. Bovis [15]. Both pathogens have a wide host range and can be found in fish, reptiles, birds and (marine) mammals worldwide [20]. The most common manifestation of tuberculosis is pulmonary disease, but nearly all organ systems can be involved, such as the lymph nodes, pleura, bones and joints [7]. 

Tuberculosis in elephants
Tuberculosis in captive elephants is most frequently caused by M. tuberculosis, although infection with M. bovis also occurs. Davis et al (2001) speculate that humans probably introduced tuberculosis into the elephant population centuries ago [4]. In elephants infected with M. tuberculosis clinical signs are often absent or only shown in the terminal stages of chronic disease [5][8]. Clinical signs are comparable to those observed in humans and may include weight loss, anorexia, weakness, dyspneu, coughing, and exercise intolerance. Transmission of tuberculosis occurs by aerosolization of infected respiratory droplets when the animals cough, trumpet or trunk spray. Transmission is influenced by the bacterial load, droplet size, length of exposure, proximity to the infected animal and immune status of exposed individuals. Tuberculosis can only be transmitted from elephants with active pulmonary disease following primary infection or after reactivation of latent infection [5].

Tuberculosis: risk for humans and elephants
Transmission from elephants to other animals and even humans has been described. Michalak et al. (1998) conducted research in an exotic animal farm in Illinois, USA, in which three elephants died of tuberculosis and one was found culture-positive. From the twenty-two animal handlers, who had moderate to frequent animal contact, eleven showed positive result with the tuberculin skin test (discussed below). Transmission between elephants and human was strongly suggested by DNA finger printing demonstrating the same pathogen strain in both an animal handler with culture-positive active tuberculosis and the dead elephants [12]. Oh et al. (2002) examined a tuberculosis infection in a Los Angeles Zoo in which DNA fingerprinting suggested transmission between two Asian elephants, three Rocky Mountain goats and one rhinoceros. Of the LA Zoo employees 18% showed a positive result on tuberculin skin tests, but no clinical symptoms or radiographic findings [14]. Davis et al. (2001) emphasize that people must be working in close proximity to, and have more than incidental contact with an infected elephant for transmission of the disease to occur. Activities such as blowing off or cleaning elephants, executing trunk washes, other medical procedures, and attending necropsies, increase potential for human exposure to tuberculosis, as mentioned by these authors [4]. They agree with Michalak et al. (1998) who state that there has to be ‘prolonged and close contact’ between elephant and human for transmission to occur [12]. All together, these publications confirm that there is a substantial risk for transmission of tuberculosis from elephant to human, especially for people working in close contact with the elephants.

And how about the risk for elephants? Tuberculosis is a major global health problem: up to one third of the world’s population is infected with M. tuberculosis. The World Health Organization (WHO) estimates that 8 million new cases and 1.9 million deaths occurred in 2000 due to tuberculosis, making the disease the second leading cause of death, exceeded only by HIV/AIDS. Tuberculosis occurs worldwide, but 95% of cases and 98% of deaths occur in developing countries, especially in sub-Saharan Africa and Asia [7]. As in Thailand the number of patients with tuberculosis is increasing with the increased incidence of HIV, a further increase in the infection rate among people and animals, especially elephants, is feared [20]. 

Immune response to tuberculosis infection
After inhalation, infectious droplet nuclei containing viable tubercle bacilli are deposited in the lung. Here, they invade the alveolar epithelial cells or they are phagocytosed by alveolar macrophages and dendritic cells. Macrophages and dendritic cells present the mycobacterial antigens on their major histocompatibility complex (MHC) proteins to T-lymphocytes with appropriate antigen-specific receptors [7]. CD4 T-lymphocytes are the T-lymphocytes who play a key role in the host immune response to tuberculosis. They regulate the acquired cellular immune response which provides protection against mycobacteria, but they also participate in the development and evolution of the infection, chronic reactivation and tissue damage [9]. During the immune response, two separate waves of cytokine-producing CD4 T-lymphocytes can be discriminated: T-helper 1 (Th1) and T-helper 2 cells (Th2) [15][21].

The first wave consists of Th1 cells. Th1 cells promote cell mediated immunity (CMI) by activating macrophages and by stimulating antigen presentation through regulation of the MHC protein expression. They participate in delayed type hypersensitivity (DTH), which may be measured by the tuberculin skin test (discussed below), and they seem to induce a primary antibody response [15]. IFN-γ, the mayor cytokine produced by Th1 cells, is considered critical for the control of mycobacterial infection [21]. After in vitro infection of mice CD4 T-lymphocytes with mycobacterial antigens, copious amounts of this IFN-γ cytokine are measured between day 10 and 30 post inoculation, with its decline starting after day 30 [15]. 

During progression of the infection, immune responsiveness tends to switch towards the Th2 type [2]. A rise in the level of the major cytokine IL-4 can be measured starting from day 30 after in vitro inoculation of CD4 T-lymphocytes with mycobacterial antigens [15]. By antagonising the Th1 cell response, Th2 cells deviate the initial CMI towards a humoral immune response [9]. They are important in controlling isotype switching to secondary antibody responses [15].

In hosts with a competent immune system, the initial interactions between the bacillus and the host cells lead to induction of specific acquired immunity against tuberculosis [7]. Infection with mycobacteria can eventually result in the formation of granulomas. The core of a granuloma exists of infected and killed macrophages, which are surrounded and infiltrated by T-lymphocytes. Granulomas are formed to control and to constrict the infection, but they may ultimately turn into necrotic or even calcified lesions and cause significant tissue damage [21].

Diagnosing tuberculosis
Early in tuberculosis infection, when the mycobacteria reside mostly within macrophages, little if any free antigen is able to evoke an antibody response. Consequently, measurement of the CMI (IFNγ & DTH) rather than the humoral response (antibodies) may indicate an early tuberculosis infection. However, if an elephant develops active tuberculosis and the bacterial and antigenic load increase, antibodies and free antigen can be detected in the blood, as depicted in figure 1 [2]. Figure 2 gives a good overview of the ability of some tests (which will be discussed below) to detect infection of tuberculosis in cattle. This figure clearly illustrates the decline of the CMI and the rise of the antibody level during progression of infection.

Definitive antemortem diagnostic techniques for tuberculosis in elephants have limitations. No single diagnostic test provides optimal sensitivity, specificity, or possibilities for use in the field; making them inadequate for effective disease management. The major diagnostic tests for detecting tuberculosis will be discussed here in three categories: 
1) Direct identification of tubercle bacilli 
2) Measurement of the CMI
3) Serology

1) Direct identification of M. tuberculosis/M. bovis
Identification of tuberculosis by culture of a trunk wash sample is the only officially recognised diagnostic test, the gold standard. This test has only been validated in domestic cattle, bison, and Cervidae [13]. There is a growing body of evidence that this test has poor sensitivity, as it can only identify animals with extensive shedding of mycobacteria which usually occurs in the late course of disease [11]. False negative results may further be caused by insufficient mycobacterial numbers in trunk secretions (<100 organisms/ml), inadequate collection procedures, contamination with other nontuberculous mycobacteria, intermittent mycobacterial shedding, and improper sample handling. Another drawback of this test is the fact that culturing of the trunk wash may take up to eight weeks, creating an opportunity for an infected elephant to disseminate mycobacteria in its environment and infect others [3]. 


















2) Measurement of the CMI
The tuberculin skin test, which measures a delayed-type hypersensitivity (DTH) response based on immunological recognition of mycobacterial antigens in exposed animals [2], shows poor sensitivity (16.7%) and specificity (74.2%) in elephants [5]. Similar to the Mantoux test applied in humans, a small volume of purified protein derivative (PPD), prepared by precipitation of proteins of heat-killed cultures of M. tuberculosis, is injected into the skin and skin reactivity is measured 72 hours later. As most of the protein components of the PPD are shared between mycobacterial species, elephants sensitized by prior exposure to non-tuberculosis mycobacteria may respond to PPD the same way as elephants that have actually been infected with M. tuberculosis [3]. Another drawback of this test is that intradermal application is not possible in elephants. The test has to be executed on the conjunctiva, which is very unpleasant for elephants, causing a lot of stress and restraint. A limitation of this test is also the lack of objectivity when reading the test result, and in case of uncertainty it cannot be repeated for 2 months due to desentization [1]. In addition elephants have to be kept under observation for 72 hours, which may be hard to realise when screening elephants on large scale or in the wild. 

A good alternative is the IFNγ release assay. This test detects the release of IFNγ in whole blood cultures, which have been stimulated overnight with mycobacterial antigen, using an enzyme-linked immunosorbent assay. The IFNγ release assay is able to detect infected animals early in disease, but the sample should be processed within 6-8 hours. This is often impossible in field conditions. Wood and Jones (2001) evaluated several studies on sensitivity and specificity of conventional tests in cattle in different countries, and reported a median sensitivity of 87.6% and a median specificity of 96.6% of this IFNγ release assay [17]. 

3) Serology
As illustrated in figure 1 and 2, antibodies can be detected in the blood during progression of the infection. Alternatives to the tests mentioned above, are rapid blood tests such as the Elephant TB STAT-PAK test and, as yet experimental, the Dual pathway platform (DPP) test, both using lateral flow technology [11]. These tests show high sensitivity and specificity, for example the 100% sensitivity and 97% specificity claimed by the producer of the TB-STAT-PAK test [22]. Rapid tests are quick and handy to use, but they are too expensive to be used on large scale in Thailand and other developing countries. The latter is also true for the MAPIA (multi-antigen print immuno assay), that defines specificity of antibodies in more detail [3].

Another, cheaper possibility to detect antibodies upon progression of infection is the multiple-antigen ELISA test. Larsen et al. (2000) found a 100% and a 95% specificity of a multiple-antigen ELISA test employing CF, PPD, MPB70, ERD, RA and AVPPD antigens [10]. The ESAT-6 and CFP10 antigens, which can be found in M. tuberculosis and M. Bovis, may also be used in this ELISA test. Greenwald et al. (2009) found that ESAT-6 and CFP10 are the immunodominant antigens recognized by elephant antibodies during disease [8]. In addition, Aagaard et al. (2006) tested several antigens on their potential as diagnostic markers for tuberculosis in cattle, using MAPIA, and found ESAT6 and CFP10 to be the superior diagnostic antigens. They also found a synergistic effect on sensitivity when combining these antigens [1]. The genes encoding for ESAT6 and CFP10 antigens are absent in most non-tuberculous mycobacteria and deleted in all BCG vaccine strains, minimizing the risk of false positive results [2]. The ELISA blood test operating ESAT6 and CFP10 antigens should thus be able to diagnose animals infected with TB, although only upon progression of infection. 
















Set up of the research project
The aim of this research project was to contribute to the development of the IFNγ capture assay and the multiple-antigen indirect ELISA test, which both have not been developed and evaluated for use in Asian elephants yet. In Kasetsart University, Bangkok, I contributed to the development of the IFNγ capture assay, as depicted in figure 3.  I worked on the expression of IFNγ by insect cells, to be used as a positive control during development of the assay; potentially for immunisation of mice to raise monoclonal antibodies for capture and detection of IFNγ in a capture ELISA. In Chiang Mai University, I run three different iELISA tests, employing the recombinant antigens ESAT6, CFP10, and MPB83, on 144 elephant sera and compared the result with the TB STAT-PAK rapid test outcome and TB status (confirmed by trunk wash culture or necropsy) of the elephants.


	Part I: Expression of glycosylated IFNγ from insect cells





Construction of a T&A vector
We started with dead BL21 cells, stored in glycerol at -80°C, containing a pET15 vector with IFNγ insertion. After taking some colonies into 20 μl of TE, boiling them at 10 minutes at 100°C, and centrifuging for 5 minutes at 13.000 rpm; we run PCR on the supernatant with 52-IFN-1W and 52-IFN-2W primers (see table 1 for sequence) with annealing at 53°C, 30 cycles. 5 μl of the PCR product was loaded into a 1.5% agarose gel and checked with UV-light camera. The bands were cut from the gel and purified with GeneJETTM Gel Extraction Kit (Fermentas). The product was ligated into a T&A vector (T&A Cloning Vector Kit (RBC Bioscience) as indicated on the kit instructions and incubated for 15 hours at 15°C. DH5α E.coli cells were prepared following instructions of TransformAidTM Bacterial Transformation Kit (Fermentas) and incubated overnight. The T&A vector was then transformed into the DH5α cells on an agar plate containing 100μg/ml ampicilline. We incubated the plate for 16 hours in a water-jacketed incubator at 37°C. The next day, 20 colonies were picked from the plate and checked with PCR using 52-IFN-1W and 52-IFN-2W primers (annealing at 53°C, 30 cycles). We cut the band from the gel, purified the DNA from the gel using the GeneJETTM Gel Extraction Kit (Fermentas) and send it for sequencing. In order not to lose time, we did not wait for the sequencing result but continued the work. We grew some colonies, which showed IFNγ insertion (as judged by size of the PCR product) into 20 ml LB broth containing 100µg/ml ampicilline, 18 hours in a shaking incubator at 37°C, 250 rpm. The plasmids were extracted from the LB broth using the Nucleospin® Plasmid (Macherey-Nagel) kit and extraction was checked with gel electroforesis. 

Cutting the gene from the vector
The next step was to cut the gene from the plasmid to enable transfection into a pMT vector. We used the FastDigestTM EcoRI kit (Fermentas), employing two partial cuts. As depicted in figure 4, our plasmid contained three different cutting sites for BglII. By employing a first partial cut with BglII and a second cut with KpnI, we would be sure that the fragment obtained, would contain our gene in the right alignment and not reversed (when employing a double digestion, you need sequencing to be sure that your gene is not reversed). We tried this digestion procedure several times, using different concentrations of plasmid (up to 10 μl), different incubating times (up to 3 hours), and new buffer. Unfortunately, we only succeeded the first cut. Sequencing showed us a normal alignment so the reason for this failed cutting was not understood. That’s why we constructed a new T&A vector with different cutting sites, as depicted in figure 5. We run PCR using 52-IFN-2W & 52-IFN-3W primers (annealing at 53°C, 30 cycles) on the colonies containing the former T&A vector, and ligated the PCR product into a new T&A vector using the same cloning kit. We transformed, checked the colonies with PCR, and grew the colonies in LB broth as described above. After extraction of the plasmid and checking the extraction with gel electrophoresis to assess PCR product sizes, we tried to cut the plasmid again. We tried a first partial cut with KpnI and a second cut with BamHI. Both procedures were executed with 10 μl of plasmid, incubating for 3 hours at 37ºC, and a final enzyme inactivation step for 10 minutes at 80ºC. Again only the first cut succeeded. We rechecked our plasmids again with different primersets, but they all showed IFNγ insertion. We reconsidered the cutting process. As the gel showed us only one band after the first cut, we were sure that the gene alignment was correct, so we could do a double digestion. We added both enzymes at the same time and after 3 hours at 37ºC and 10 min at 80 ºC, we finally succeeded to cut the gene from the plasmid. 

Transformation of the gene into pMT vector and transfection into insect cells



















Sequences of primers used in this experiment 


	Part II: evaluation of multiple-antigen iELISA blood test & rapid test 

Elephants
144 Blood- and trunk wash samples were taken from 25 elephants from the National Elephant Institute hospital, Lampang, Thailand, during a period of five years. The elephants differ in age, sex, origin and background. Some elephants had already died.

Samples
Trunk wash samples were collected by instilling 150 ml of saline into the trunk and recollecting the liquid into a plastic bag. If the elephant was properly trained, this procedure was repeated two more times. The samples were stored at -20°C and processed within a week. Blood samples were collected from the ear vein, processed to sera, and stored at -20°C. 

Tests
A. Trunk wash culture
Trunk wash culture samples were cultured following the standard operating procedure for trunk wash culture from dr. J.B. Payeur, United states Department of Agriculture, National Veterinary Services Lab. Only the L-J slant & L-J gruft slant media have been used in this experiment.

B. Commercial test kit (Rapid Test, RT)
The Elephant TB STAT-PAK® Assay (Chembio) was used to test the elephant sera, as indicated on the test kit’s instructions. The test results were interpreted by eye. Unclear results were considered negative. 

C. iELISA





Tuberculosis (TB) status (infected-not infected), confirmed by trunk wash culture and/or necropsy, was used as a gold standard to evaluate the iELISA and TB STAT-PAK test results. As TB status was only confirmed for 21 elephants, 118 out of the 144 samples were used for data analysis. From the raw iELISA data, the mean OD from each sample (added in triplicate), 30 minutes after adding ABTS, was calculated by Excel. Next, the S/P ratio, which corrects for the differences in between plates, was calculated by hand for each sample using the formula 

S/P:            mean OD sample - mean OD negative control         x  100%
mean OD positive control - mean OD negative control 
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	Part I: Expression of glycosylated IFNg from insect cells














Figure 6                                                  Figure 7
Dead BL21 cells showing IFNγ	        T&A clones no.1,2,4,5,8-11 showing IFNγ gene insertion using
gene insertion using 52-IFN-1W	        IFN-1W & M13re primers. NC=negative control.    
















First partial cut of the second T&A vector		Second cut of pMT and second T&A vector using 
with KpnI enzyme(succeeded).			BamHI enzyme (FAILED: only one band!).
MK=marker, C=T&A vector,			MK=marker, PC/IC=intact pMT/T&A vector, 




Double digestion of second T&A vector with KpnI & BamHI enzymes (succeeded). Only the T&A vector shows two bands as the fragment cut from the pMT vector is too small to be shown in the gel. PMT=pMT vector digestion product, E2=T&A vector digestion product.


	Part II: evaluation of multiple-antigen iELISA blood test & rapid test 

TB STAT-PAK test: association with TB status
Pearson Chi-square testing indicated that there is an association between the rapid test result and elephant TB status. Further test characteristics are discussed below.

iELISA: mean S/P ratio and hypothesis testing
Two sample t-tests determined significant differences in mean S/P ratios between the infected and noninfected groups with ESAT6/CFP10, CFP10 and MPB83 iELISA testing (see table 3). This means that the null hypothesis H0: μ+=μ- is to be rejected.
When calculating the standard error of the mean (SEM), it shows us that the given mean S/P ratios are quite adequate estimates of the population mean, especially for the ESAT6/CFP10 iELISA test. This also proves the null hypothesis can be rejected.

iELISA	Infected (n=20)	Noninfected (n=98)
ESAT6/CFP10	75.70 (± 7.75)	17.15 (± 1.32)
CFP10	58.80 (± 9.12)	23.13 (± 1.33)
MPB83	41.94 (± 12.07)	26.95 (±1.70)
Table 3
Mean S/P ratio and standard error of the mean (SEM) of different iELISA tests, calculated for samples from infected and noninfected elephants. The null hypothesis H0: μ+=μ-  can be rejected. The SEM shows that the given S/P ratios are quite adequate estimates of the population mean.

iELISA: cut off points
The ROC curve of the ESAT6/CFP10, CFP10 and MPB83 iELISAs are shown in figure 11, 12 and 13. The ESAT6/CFP10 iELISA shows the most optimal curve with cut off points with a high sensitivity and specificity; the curves of CFP10 and MPB83 iELISA are less optimal. The red arrows in each curve indicate the cut off points which have been compared in the figures 14-16 and tables 4-6. For the ESAT6/CFP10 iELISA, nwec2 with a value of 55.14 was chosen as the cut off point. Although nwec1 showed the highest sensitivity, nwec2 showed a significantly higher area under the ROC curve (chi-square tested), higher correctly classified percentage, a much higher positive predictive value (88.24% for nwec2 versus 64% for nwec1) and a higher specificity (see figure 14 and table 4). Choosing a cut off point for the CFP10 iELISA was somewhat easier. Although its somewhat lower percentage of correctly classified values, ncfp1 with a value of 32.25 shows the highest sensitivity and a significantly higher area under the ROC curve (see figure 15 and table 5). Finally, for the MPB83 test, determining the cut off point was a real challenge. Nmpb3 with a value of 28.56 seems to be the best pick because of its much higher percentage of correctly classified values and a significantly higher are under the ROC curve (see figure 16 and table 6).

iELISA and TB STAT-PAK: test characteristics










ROC curve of all possible cut off values of CFP10 iELISA. The red arrows indicate possible cut off points.

Figure 13





ROC curve of nwec1, nwec2 and nwec3 cut off points of the ESAT6/CFP10 iELISA test.









































Characteristics of three suitable cut off points for MPB83 iELISA as calculated by STATA™. Nmpb3 was chosen as the cut off point as much higher percentage of correctly classified values and a significantly higher area under the ROC curve.






















The aim of this research project was to contribute to the development of an IFNγ assay by working on the expression of IFNγ by insect cells, and to evaluate iELISA tests employing ESAT6/CFP10, CFP10 & MBP83 antigens and the commercial TB STAT-PAK rapid test.

As concerned the IFNγ expression, this process is not finished yet. We experienced a lot of problems with the digestion of the T&A vector. This may be caused by a low accuracy of the commercial kit that was used. This kit worked with the volume of DNA and enzymes instead of concentration, which is less specific. It would have been better to determine the concentration of the DNA and adjust the amount of enzyme to this concentration, in order to optimize the digestion process. Eventually the investigators succeeded in constructing a pMT/BiP/V5-HisA vector carrying an IFNγ gene insertion (as assessed by PCR product size). This plasmid has been transferred into Schneider 2 insect cells (Drosophila melanogaster), using the Drosophila Expression System (DES®, Invitrogen). A stable expression of IFNγ by these cells has not been established yet

Compared to the 100% sensitivity and 97% specificity claimed by the producer of the TB STAT-PAK test, in this project a sensitivity of 80% and a specificity of 87.23% were found (using Win Episcope 2.0 software). The iELISA test employing the immunodominant antigens ESAT6 & CFP10, showed a sensitivity of 75% and a specificity of 97.82%, and a positive predictive value of 88.24% opposed to the positive predictive value of 57.14% of the TB STAT-PAK test. Calculation of sensitivity and specificity with the STATA™ program showed an equal sensitivity of 80% for both the ESAT6/CFP10 iELISA and the rapid test and a higher specificity (97.82%) of the iELISA test compared to the 84.69% sensitivity of the TB STAT-PAK test. This means that the ESAT6/CFP10 iELISA could be a good alternative to the expensive TB STAT-PAK test when screening for TB infection in Asian elephants. 

As in every investigation, there are quite some remarks about the statement above. As the TB status was only confirmed for 21 of the 25 elephants, only 118 out of 144 samples were used in the research. In the near future, the trunk wash culture result will be known of the additional four elephants, extending the sample group to 144 samples from 25 different elephants. Still, these samples originate from only a few animals, resulting in dependent data. In this data analysis, the data have been considered to be independent which may have resulted in an inaccurate calculation of test characteristics. Additionally, elephants were considered to be infected when necropsy and/or trunk wash culture gave a positive result. Trunk wash culture is considered the gold standard, although there is growing body of evidence that this test has a low sensitivity [10][11]. Thus, this test might have missed out on some positive elephants, affecting the test characteristics of the iELISAs and the rapid test, although the elephants have been under close health supervision and no clinical signs of the negative animals have been reported yet. Necropsy and culture would be the ideal gold standard in this investigation, but considering the life span of the elephant this was not possible here. 

Other factors that could have influenced the results are the difference in sera quality (as they have been collected under different circumstances by different veterinarians, during five years) and the occurence of quite some negative OD values and thus negative S/P ratios in the data (due to the use of a negative control which wasn’t really negative?). It would be useful to develop a method to account for this negative data and recalculate S/P ratios and test characteristics, or run the iELISA tests again with a different negative control. During this improved analysis, I would recommend to use only one software program instead of the two different software programs used in my analysis. 
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1.	NUNC MaxiSorp ELISA plates were coated with either an ESAT6/CFP10 antigen combination 1μ/ml (liquid solution produced at Statens Serum Institute, Copenhagen, Denmark), CFP10 antigen 1μ/ml, (Statens Serum Institute), or MPB83 antigen 1μ/ml, (powder dissolved in distilled water, origin Ireland), 50 μl per well. Plates were incubated on a shaking plate for 60 minutes, and washed one time with 0.1% TWEEN 20 solution (PBS).
2.	The wells were blocked with 1x blocking reagent, 200 μl per well. The plates incubated on a shaking plate for 15 minutes and washed one time with 0.1% TWEEN 20 solution (PBS).
3.	Then, the elephant sera were added, as indicated in table 2. On each plate, 29 different elephant sera, diluted 1:800 into PBS, were added in triplicate, 60 μl per well. Positive and negative controls were added on each plate. The plates were incubated for 120 minutes on a shaking plate, and then washed 3 times with 0.1% TWEEN 20 solution (PBS).
4.	Monoclonal anti-elephant rabbit antibodies (obtained after six weeks of immunization of rabbits with 500µg elephant IgG injected three times every two weeks, and stored in sodium azide) were then added, diluted 1:8000 into PBS, 50 μl per well. The plates were incubated for 30 minutes on a shaking plate and then washed 3 times with 0.1% TWEEN 20 solution (PBS).
5.	Purified peroxidase labeled anti-rabbit goat antibodies (KPL) dilution 1:2000 (PBS) were added 50 μl per well. The plates were incubated for 30 minutes on a shaking plate, and then washed 5 times with 0.1% TWEEN 20 solution (PBS).
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Table 2







Goat polyclonal antibodies to rabbit polyclonal antibodies



























Rabbit polyclonal antibodies to serum antibodies





























Rabbit polyclonal antibodies to chicken anti-IFNγ 













































Schematic presentation of the IFNγ capture ELISA (modification of design of prof. dr. V. Rutten)

Figure 5




Schematic representation of the first T&A vector with gene insertion (green box) and its cutting sites using 52-IFN-1W & 52-IFN-2W primers. The arrows indicate the preferred cutting sites.
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Serum containing antibodies to ESAT-6 and CPF-10
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